Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery

• Status: Unknown status
• Trial end date: 2016-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine the efficacy of dose regimen of serratiopeptidase (serodase 5 mg) as a prospective, randomized, parallel, double blind Placebo- controlled study.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hayat Pharmaceutical Co. PLC
• Treatments: Serratiopeptidase

Criteria

Inclusion Criteria:

• participants presented with impacted lower wisdom tooth needs Buccaneers flap with buccal and distal bone removal.

• male or female 18-50

• participant is willing and able to give informed consent for paricipation in the study.

• Able and willing and able with all study requirments.

Exclusion Criteria:

• other oral surgical procedures during the same session except the removal of supernumerary third molars.

• female subject who is pregnant or lactating

• subjects has participated in any clinical research study within the previous 8 weeks.

• subjects on anti coagulant drugs .

• Unwilling participants to continue the study and those with abnormality of wound healing process.